A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.

por Vlasveld, L. T., Rankin, E. M., Hekman, A., Rodenhuis, S., Beijnen, J. H., Hilton, A. M., Dubbelman, A. C., Vyth-Dreese, F. A., Melief, C. J.
Publicado 1992

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.

por Vlasveld, L. T., Hekman, A., Vyth-Dreese, F. A., Rankin, E. M., Scharenberg, J. G., Voordouw, A. C., Sein, J. J., Dellemijn, T. A., Rodenhuis, S., Melief, C. J.
Publicado 1993

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

por Weimar, I S, Weijer, K, Berk, P C M van den, Muller, E J, Miranda, N, Bakker, A Q, Heemskerk, M H M, Hekman, A, Gast, G C de, Gerritsen, W R
Publicado 1999